Literature DB >> 12517936

CD4+ T cells from lupus-prone mice avoid antigen-specific tolerance induction in vivo.

Farida Bouzahzah1, Sungsoo Jung, Joseph Craft.   

Abstract

Activated T cells in spontaneous lupus presumably bypass normal tolerance mechanisms in the periphery, since thymic tolerance appears intact. To determine whether such T cells indeed avoid in vivo peripheral tolerance mechanisms, we assessed their activation and recall responses after in vivo Ag stimulation in the absence of exogenously supplied costimulatory signals. Naive CD4(+) AND (transgenic mice bearing rearranged TCR specific for pigeon cytochrome c, peptides 88-104) TCR-transgenic T cells, specific for pigeon cytochrome c, from lupus-prone Fas-intact MRL/Mp+(Fas-lpr) and from H-2(k)-matched control CBA/CaJ and B10.BR mice (MRL.AND, CBA.AND, and B10.AND, respectively) were adoptively transferred into (MRL x CBA)F(1) or (MRL x B10)F(1) recipients transgenically expressing membrane-bound pigeon cytochrome c as a self-Ag. MRL.AND and control CBA.AND and B10.AND-transgenic T cells were activated and divided after transfer, indicating encounter with their cognate Ag; however, T cells from CBA.AND and B10.AND mice were impaired in their ability to proliferate and produce IL-2 after challenge with pigeon cytochrome c in ex vivo recall assays, a typical phenotype of anergized cells. By contrast, MRL.AND T cells proliferated more, and a significantly higher percentage of such cells produced IL-2, compared with control T cells. This observation that MRL T cells avoided anergy induction in vivo was confirmed in an in vitro system where the cells were stimulated with an anti-CD3 in the absence of a costimulatory signal. These experiments provide direct evidence that CD4(+) T cells from Fas-intact lupus-prone MRL mice are more resistant than nonautoimmune control cells to anergy induction. Anergy avoidance in the periphery might contribute to the characteristic finding in lupus of inappropriate T cell activation in response to ubiquitous self-Ags.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517936     DOI: 10.4049/jimmunol.170.2.741

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Drugs, sun and T cells in lupus.

Authors:  G C Tsokos
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 2.  T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens.

Authors:  Syamal K Datta; Li Zhang; Luting Xu
Journal:  J Mol Med (Berl)       Date:  2005-01-04       Impact factor: 4.599

3.  Dendritic cells from lupus-prone mice are defective in repressing immunoglobulin secretion.

Authors:  Mileka R Gilbert; Diane G Carnathan; Patricia C Cogswell; Li Lin; Albert S Baldwin; Barbara J Vilen
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

Review 4.  HDAC inhibition in lupus models.

Authors:  Christopher M Reilly; Nicole Regna; Nilamadhab Mishra
Journal:  Mol Med       Date:  2011-02-11       Impact factor: 6.354

5.  Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage.

Authors:  Vijay Saxena; Douglas W Lienesch; Min Zhou; Ramireddy Bommireddy; Mohamad Azhar; Thomas Doetschman; Ram Raj Singh
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

6.  Inducible nitric oxide synthase in T cells regulates T cell death and immune memory.

Authors:  Monika Vig; Smita Srivastava; Usha Kandpal; Hadassah Sade; Virginia Lewis; Apurva Sarin; Anna George; Vineeta Bal; Jeannine M Durdik; Satyajit Rath
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 7.  T-helper cell tolerance to ubiquitous nuclear antigens.

Authors:  B Nakken; K E Davis; Z J Pan; M Bachmann; A D Farris
Journal:  Scand J Immunol       Date:  2003-11       Impact factor: 3.487

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.